Novo Nordisk to Halve U.S. List Prices for Ozempic and Wegovy
According to the Wall Street Journal, the Danish pharmaceutical firm plans up to a 50% cut for its key weight-loss and diabetes drugs in the United States.
Summary
No Summary provided as the original text is short
Terms & Concepts
Ozempic: A prescription medication developed by Novo Nordisk for managing type 2 diabetes and, in some cases, supporting weight loss.
Wegovy: A weight-loss drug by Novo Nordisk that contains semaglutide, similar to the ingredient used in Ozempic.